Land: Storbritannien
Sprog: engelsk
Kilde: VMD (Veterinary Medicines Directorate)
Tramadol hydrochloride
Le Vet Beheer B.V.
QN02AX02
Tramadol hydrochloride
Chewable tablet
POM-V - Prescription Only Medicine – Veterinarian
Dogs
Neurological Agent analgesic
Authorized
2018-07-09
Revised: April 2022 AN: 02906/2021 Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Tralieve 20 mg chewable tablets for dogs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 20 mg tablet: 1 tablet contains: ACTIVE SUBSTANCE: Tramadol hydrochloride 20 mg equivalent to 17.6 mg tramadol EXCIPIENT(S): For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Chewable tablet. 20 mg tablet: Light brown with brown spots, round and convex flavoured 7 mm tablet with a cross-shaped break line on one side. Tablets can be divided into 2 or 4 equal parts. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Dogs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the reduction of acute and chronic mild soft tissue and musculoskeletal pain. 4.3 CONTRAINDICATIONS Do not administer in conjunction with tricyclic antidepressants, monoamine oxidase inhibitors and serotonin reuptake inhibitors. Do not use in cases of hypersensitivity to tramadol or to any of the excipients. Do not use in animals with epilepsy. 4.4 SPECIAL WARNINGS The analgesic effects of tramadol hydrochloride may be variable. This is thought to be due to individual differences in the metabolism of the drug to the primary active Revised: April 2022 AN: 02906/2021 Page 2 of 6 metabolite O-desmethyltramadol. In some dogs (non-responders) this may result in the product failing to provide analgesia. For chronic pain, multimodal analgesia should be considered. Dogs should be monitored regularly by a veterinarian to ensure adequate pain relief. In case of recurrence of pain or insufficient analgesia the analgesic protocol may need to be reconsidered. 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Use with caution in dogs with renal or hepatic impairment. In dogs with hepatic impairment the metabolism of tramadol to the active metabolites may be decreased which may reduce the efficacy of the product. One of the active metabolites of tramadol is renally excreted and therefore in dogs with renal impai Læs hele dokumentet